Warren Buffett focuses on vaccine makers Pfizer and Merck

Super investor Warren Buffett sees the most in the coronavaccins of Pfizer and Merck. With its investment vehicle Berkshire Hathaway, the multibillionaire has bought shares in those two companies.

In addition, Berkshire focuses on pharmaceuticals ABBVie and Bristol-Myers Squibb. At the same time, the multibillionaire lowered his interests in financial companies, including Wells Fargo and JPMorgan Chase, as emerges from documents from the third quarter.

Berkshire had already started buying shares in health companies before Pfizer announced last week that his candidate vaccine was 90% effective in clinical trials. Merck supports research into more than fifty potential corona vaccines and is also investigating a medicine for the treatment of pneumonia in coronavirus patients.

Buffetts company held at the end of the third quarter in ABBVie, Bristol-Myers Squibb and Merck each held a stake of more than 1.8 billion dollars and approximately 136 million dollars in Pfizer. The investment company slightly reduced the stake in Wells Fargo, and reduced the investment in JPMorgan by as much as 96 percent.

Buffett often shakes up his stock portfolio. Earlier this year, the investor disposed of all its shares in four major airlines.